about
MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.Quality of life in patients with pituitary tumors.Clinical consequences of Cushing's syndrome.The value of a European registry for pituitary adenomas: the example of Cushing's syndrome registry.Quality of life in Cushing's syndrome.Health-related quality of life in pituitary diseases.Quality of life in patients with hypopituitarism.Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.Cushing's syndrome and pregnancy outcomes: a systematic review of published cases.Reduced DNA methylation of FKBP5 in Cushing's syndrome.Cortisol Excess and the Brain.Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids.Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy.Effects of illness duration and treatment resistance on grey matter abnormalities in major depression.Relationship between adiponectin and left atrium size in uncomplicated obese patients: adiponectin, a link between fat and heart.The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics.Affective alterations in patients with Cushing's syndrome in remission are associated with decreased BDNF and cortisone levels.Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acromegaly.A specific nursing educational program in patients with Cushing's syndrome.Differences in attention and impulsivity between borderline personality disorder and bipolar disorder.Small cerebellar cortex volume in patients with active Cushing's syndrome.White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: a DTI study.Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice.Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome.Preoperative medical treatment in Cushing's syndrome. Frequency of use and its impact on postoperative assessment. Data from ERCUSYN.[Role of health-related quality of life in clinical practice: subjectivity in evidence].Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.Quality of Life in Cushing's disease: A long term issue?Telomere length analysis in Cushing's syndromeTelómeros, envejecimiento y síndrome de Cushing: ¿están relacionados?
P50
Q34461204-053F48F2-ACE4-4559-B098-2547D21D63DEQ35208064-DAB2D847-7118-4098-9A05-FB2680D109F6Q37505947-73F3F407-BB0A-40D7-B65E-832A5831A4A7Q38004913-5A6E10B2-4E4C-4B98-9442-91505EC71BE2Q38006182-D63DA8F5-B320-4385-AB94-1450F848E881Q38342515-AA0E66CA-B851-4842-9308-9DE904B4E4E8Q38366920-474D9D52-3643-44CB-AD46-93033FC4D444Q38535497-A79C3CF9-DB5F-43BC-9318-C8E4F05C17F9Q38845049-4A011F49-0727-4ED8-9180-7FC46062BFB6Q38972540-90BFF903-4792-4AB6-A42C-FB32727ECE35Q39355482-EE69C4EC-0AB9-43D5-8F95-4FAFDF6D173AQ39745935-F1EF0D3D-CB67-4209-A707-0E353A05710EQ41189660-5F5BE9CC-F134-4FC4-8246-1AC78DC84ADEQ43049394-4A95DAF7-CA50-4671-BCFB-EB4A90B0A34BQ45127728-4004AA86-AD73-4A3A-8E66-A420D9FAF9B0Q45182183-38560B0F-C5E2-4374-BF83-9B108E2106D1Q45921093-303D6B3B-AA26-4522-A0FD-DBA640B6D41AQ46162746-5C81F47F-E1CA-40FB-846D-9A5A2223AC1AQ47364749-FAC517AC-A427-4690-A065-D25D219FB0EBQ47438094-C0E270B3-4E26-401F-AC88-5383605DD9AEQ47693258-3A18361A-A750-433C-BDD8-0E21DA4A6066Q47933955-6418BB76-AE24-44F3-A2C3-166508FC4CA9Q47973893-157E648B-8D2E-4A73-B35C-AA61AFDAC49FQ48071251-18B73117-9BEF-4FF0-8F1C-E25D5EF5EE8DQ48199852-E9C779B5-7545-4B2F-8DB2-04426D4AC3B4Q48431892-AF707F3A-A395-4C9D-86A7-E91B74223DC9Q48643047-C3B07F0D-8F68-496E-91C1-D8DE124C218BQ48785850-88E59792-89AF-4791-901B-863BFCDFC0FAQ50026684-2ECC570B-168B-4B5E-90F5-476FFEC78354Q50599528-BA0FE9A0-0218-4F3F-BA6D-DD97B7F78A2AQ52806766-B788F8B0-811C-4A0E-9429-46721A1FD70BQ53823784-85AB233B-00AF-4D03-953B-6F83438DBA4EQ57961744-C8C76CA4-0155-4412-9810-A27BCAA759F7Q60636233-3DF64CBA-3FDD-4EB3-BBB2-EAA435D11F8E
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alicia Santos
@ast
Alicia Santos
@en
Alicia Santos
@es
Alicia Santos
@nl
type
label
Alicia Santos
@ast
Alicia Santos
@en
Alicia Santos
@es
Alicia Santos
@nl
prefLabel
Alicia Santos
@ast
Alicia Santos
@en
Alicia Santos
@es
Alicia Santos
@nl
P106
P21
P31
P496
0000-0002-2179-6189